Category: Blog
Transforming the NHS: Unlocking a Triple Dividend
Transforming the NHS: Unlocking a Triple Dividend By Cavendish Transforming the NHS: Unlocking a Triple Dividend In his 2024 review, Professor Lord Darzi described the NHS as “broken but not beaten.” With the right reforms, it can deliver a triple dividend for the UK: – Better outcomes and satisfaction for patients– Improved productivity within the
Navigating the energy profits levy
Categories: BlogWhat it means for the future of the UK North Sea Navigating the energy profits levy By Cavendish Introduced as a temporary measure, the Energy Profits Levy (EPL) has become a defining feature of the UK’s oil and gas landscape. But its evolution—through multiple changes—has created growing uncertainty for investors, operators, and policymakers alike. Introduced
The Wellness Brands Driving M&A Innovation
The Wellness Brands Driving M&A Innovation By Cavendish The wellness sector is thriving, with founder-led brands – many led by women – attracting significant attention from global investors. In the past year, a number of UK wellness brands were acquired by major players like Unilever and Yeo Valley Organic, reflecting the growing demand for purpose-driven
The Alumasc Group plc
Categories: BlogThe Alumasc Group plc By Cavendish Alumasc’s track record of sustainable profit and dividend growth is a testimony to its strategy to drive growth from its premium sustainability-linked products and brands, supplemented with growing exports and selective acquisitions. We are delighted to be extending our remit with the Company and look forward to supporting its
HealthTech Insights
HealthTech Insights By Cavendish HealthTech remains one of the most dynamic and resilient investment sectors, with AI-driven innovation, regulatory shifts, and evolving M&A trends shaping its trajectory. Our latest HealthTech Q1 Report provides in-depth insights into: With over £450 million in venture funding deployed in 2024 and sustained investor interest in high-quality assets, the report
London’s Capital Markets: Open for Ambitious Companies
Categories: BlogLondon’s Capital Markets: Open for Ambitious Companies By Cavendish Cavendish: Last Growth Market IPO of 2024, First of 2025.Cavendish is the leading UK investment bank for growth companies, operating across private and public markets. Cavendish ended 2024 with the final IPO of the year and has already set the tone for 2025, with the first
AIM and Growth Company IPO Forum
AIM and Growth Company IPO Forum By Cavendish “I can’t overstate what listing on AIM did for Ideagen and our progression towards becoming a tech unicorn. It offered access to vital capital, increased visibility and the support needed to scale and innovate.AIM provides a platform for small and medium-sized enterprises to turn potential into success.
RC Fornax’s AIM Debut at the LSE
RC Fornax’s AIM Debut at the LSE By Cavendish RC Fornax is a prime example of the kind of ambitious, high-growth company that AIM was designed to support. Their expertise in defence engineering, combined with a clear strategy for expansion and innovation, makes them well-positioned for continued success and rapid growth. We’re proud to have
Consumer Sub-Sector in Focus: Apparel and Accessories
Consumer Sub-Sector in Focus: Apparel and Accessories By Cavendish Cavendish’s Consumer Quarterly Report reviewing Q4 2024, looks at some of the key themes impacting the UK consumer. For this quarter, we also explore the key M&A trends across the sector, with a spotlight on Apparel & Accessories – a sub-sector which for much of 2024
Virgin Wines
Categories: BlogVirgin Wines By Cavendish Cavendish is pleased to announce our appointment as the Nominated Adviser and Sole Corporate Broker for Virgin Wines UK PLC. Virgin Wines is one of the UK’s largest direct-to-consumer wine retailers, known for its unique wine sourcing model and blending processes, providing premium quality wine at affordable prices to a large
